Skip to Main Navigation Skip to Page Content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clonitralid: Target Organs and Levels of Evidence for TR-091

Bioassay of Clonitralid for Possible Carcinogenicity (CASRN 1420-04-8)

Chemical (Study Title) CASRN	Peer Review Date	Route/Exposure Levels	Study Laboratory
Clonitralid 1420-04-8	06/29/1978	Dosed-Feed R: 0,14216,28433 (AVG), M: 0,274,549 (AVG) PPM/50 PER GROUP	Hazleton, Vienna

Levels of Evidence

Male Rats: Negative

Female Rats: Equivocal

Type	Organ/Tissue (Lesion)
Neoplastic Lesions	Mammary Gland: (FIBROADENOMA, ADENOCARCINOMA) Glandular Stomach: (CARCINOMA)

Clonitralid: Target Organs and Levels of Evidence for TR-091

Bioassay of Clonitralid for Possible Carcinogenicity (CASRN 1420-04-8)

Levels of Evidence

Male Rats: Negative

Female Rats: Equivocal

Male Mice: Inadequate Study

Female Mice: Negative